Document is current
Any future updates will be listed below
-
Authors
Calderón, Ariana S. https://orcid.org/0000-0001-6271-6256
Ghazanfari, Roshanak
Masoumi, Zahra
Kharazi, Shabnam
Palo, Sara
Lang, Stefan https://orcid.org/0000-0002-0854-2328
Žemaitis, Kristijonas
Eldeeb, Mohamed https://orcid.org/0000-0002-8636-2189
Subramaniam, Agatheeswaran https://orcid.org/0000-0003-3966-3875
Soneji, Shamit
Stam, Ronald W. https://orcid.org/0000-0003-4986-1656
Bryder, David https://orcid.org/0000-0002-8761-4237
Böiers, Charlotta https://orcid.org/0000-0002-4876-1218
-
Funding
Funding for this research was provided by:
Barncancerfonden
Vetenskapsrådet
Cancerfonden
- License Information
-
More Information
Article History
Received: 27 December 2024
Revised: 20 May 2025
Accepted: 11 June 2025
First Online: 11 July 2025
Competing interests
: The authors declare no competing interests. Current affiliation for Shabnam Kharazi is NextCell Pharrma AB, Huddinge, Sweden, for Mohamed Eldeeb Acrivon Therapeutics, Lund, Sweden and for Zahra Masoumi Department of Biology, University of York, York, United Kingdom.
